Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02819167
Other study ID # 69HCL16_0151
Secondary ID
Status Completed
Phase N/A
First received June 28, 2016
Last updated November 16, 2017
Start date May 26, 2016
Est. completion date August 2016

Study information

Verified date November 2017
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ischemic strokes are one of the leading causes of handicap and death in elderly people in France.

Cognitive reserve (CR) is an active model, defined as a function of lifetime intellectual activities and other environmental factors that explain differential susceptibility to functional impairment in the presence of pathology or other neurological insult. CR is estimated using variables for cognitive activity: years of education, professional status, socioeconomic status… Furthermore, brain reverse (BR) is a passive and quantitative model that depend on brain size and other quantitative aspects of the brain that explain differential susceptibility to functional impairment in the presence of pathology.

Firstly, volume and localization of ischemic strokes have a great impact on CR and BR due to brain injury. On the other hand, CR influences the severity and the expression of cognitive diseases.

The investigators realize a prospective study in order to assess the impact of CR and BR on cognitive prognosis after a right middle cerebral artery ischemic stroke in elderly patients.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- =70 years old

- right middle cerebral artery ischemic stroke

- hospitalized in neurovascular unit of Pierre Wertheimer hospital between January 2015 to January 2016

Exclusion Criteria:

- Contraindication for MRI

- Hemorrhagic stroke

- Aphasia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
neurologic and neuropsychological evaluation
cognitive prognosis, cognitive reserve, brain volume will be studied on patients with scale, questionnaire, magnetic resonance imaging

Locations

Country Name City State
France Hôpital des Charpennes Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary evaluation of cognitive prognosis measure will be performed with the Mattis dementia rating scale one year post Ischemic stroke
Secondary Volume of leucoencephalopathy measure will be performed with a MRI one year post Ischemic stroke
Secondary volume of hippocampic measure will be performed with a MRI one year post Ischemic stroke
Secondary brain injury measure will be performed with a MRI one year post Ischemic stroke
Secondary volume of ischemic stroke measure will be performed with a MRI one year post Ischemic stroke
Secondary evaluation of cognitive reserve measure will be performed with the Cognitive reserve index questionnaire one year post Ischemic stroke
See also
  Status Clinical Trial Phase
Completed NCT05131295 - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. Phase 3
Completed NCT01955642 - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Recruiting NCT06076122 - Salicornia for Neurovascular Health Improve N/A
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4
Recruiting NCT06270927 - A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Completed NCT02912546 - Cerebral Perfusion Associated With Postural Changes: an ASL MR Perfusion Study N/A
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT05815836 - Precision Medicine in Stroke
Recruiting NCT01673932 - Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke Phase 1
Recruiting NCT01556802 - Use of Minocicline in Patients With Stroke Phase 1
Completed NCT02101606 - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Phase 2
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Terminated NCT00073372 - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) Phase 3
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT04188132 - EEG Based BCI for Upper Limb Rehabilitation in Stroke N/A
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Completed NCT01443962 - The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy N/A
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2